Pineiro Minerva MD - Brevard, North Carolina 28712

Pineiro Minerva MD is categorized under Doctors in Brevard, NC .

Business Name: Pineiro Minerva MD
Contact Person: Minerva Pineiro
Address: 342 South Caldwell St, Brevard, North Carolina 28712
Phone Number: (828) 883-8181
Annual Revenue (USD): $500.000 to $999.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:
Related Businesses: Paul B Duvall Md - Brevard, NC 28712
Lawson Ellen T MD - Brevard, NC 28712
Kelling Carmen G MD - Brevard, NC 28712
Lefler Charles D MD - Brevard, NC 28712
Nash A Dale MD - Brevard, NC 28712
Graham III Angus W MD - Brevard, NC 28712
Christianson Dana John MD - Brevard, NC 28712
Benton III George R MD - Brevard, NC 28712
Robertson James T MD - Brevard, NC 28712
Cross M Todd MD - Brevard, NC 28712
Atwater Spencer MD - Brevard, NC 28712
Benton III G Ruffin MD - Brevard, NC 28712
Volatile Katherine MD - Brevard, NC 28712
Kim Hongjae MD - Brevard, NC 28712
Barrow Brian P MD - Brevard, NC 28712
Pollack Gregory A MD - Brevard, NC 28712
Rackoff Andrew I MD - Brevard, NC 28712
Stombaugh Lauretta G DO - Brevard, NC 28712
Bodie Barry H MD - Brevard, NC 28712
Rholl James C MD - Brevard, NC 28712

The company Pineiro Minerva MD provides B2C services in the form of Doctors from its single location in North Carolina. 1 to 4 employees work for Pineiro Minerva MD, and the business now earns $500.000 to $999.999 per annum.

Pineiro Minerva MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 . To contact Pineiro Minerva MD, please call Minerva Pineiro with the phone number (828) 883-8181 or visit its single location at 342 South Caldwell St in Brevard, North Carolina 28712.

The location of the single location can also be found using the coordinates 35.2301,-82.73855. Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.